🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This single-arm, multi-center study is to evaluate Sugemalimab plus platinu...
Status
Recruiting
Location
cancer hospital， Chinese Academy of medical sciences and Peking union medical college
Start Date
2023-10-10
Trial ID
NCT07247227
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sugemal...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-06
Trial ID
NCT05700448
Treatments Being Tested
The goal of this phase II, open-label, single-arm study is to evaluate the ...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2023-06-14
Trial ID
NCT05940532
Treatments Being Tested
To study the safety and clinical effect of injection of drug-eluting micros...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2020-11-01
Trial ID
NCT04770207
Treatments Being Tested
This study assesses the safety and efficacy of NK510 combined with PD-(L)1 ...
Status
Recruiting
Location
Jinling hospital, affiliated to Medical school Nanjing University
Start Date
2023-07-01
Trial ID
NCT06097962
Patients with stage III non-small-cell lung cancer initially evaluated as u...
Status
Unknown
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT06031597
Treatments Being Tested
The purpose of this study was to evaluate the efficacy of sugemalimab conso...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2023-07-01
Trial ID
NCT05623267
Treatments Being Tested
This study aims to explore the efficacy and safety of immunotherapy (PD-L1 ...
Status
Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2025-02-25
Trial ID
NCT06869239
The purpose of this study was to evaluate the safety and efficacy of low-do...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2024-04-18
Trial ID
NCT06217757
Treatments Being Tested
To observe the effect of preoperative anti-PD-1 monotherapy combined with c...
Status
Completed
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-03-22
Trial ID
NCT05273827
Treatments Being Tested